A district court rejected a challenge to the acquisition of a newly developed drug by a company that owned a well-established drug used to treat the same condition because it found that the two drugs were not in the same relevant market. The U.S. Court of Appeals for the Ninth Circuit ruled that a profit-sharing agreement among Southern California supermarkets to counteract targeted strikes during a labor dispute was not shielded from antitrust scrutiny by the labor exemption. The U.S. Court of Appeals for the Federal Circuit decided that an agreement between participants in a standard-setting collaboration not to license competitive technology did not give rise to a patent misuse defense in an infringement action.
Other recent antitrust developments of note included the Department of Justice’s enforcement action challenging a leading health insurance company’s Most-Favored Nation (MFN) clauses requiring hospitals to charge rival insurers the same or higher rates.
Drug Acquisition
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
